Sudo Biosciences Funding & Investors
Carmel, IN
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Their lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked... Read more
sudobio.comTotal Amount Raised: $183,000,000
Sudo Biosciences Funding Rounds
Series B
$30,000,000
Series B Investors
Enavate SciencesTPGEventide Asset Managementsanofi-aventisSurveyor CapitalMonograph CapitalUPMCSV Health ManagersFrazier Life SciencesVelosity CapitalLeaps by BayerSeries B
$116,000,000
Series B Investors
Enavate SciencesTPGFrazier Life SciencesSurveyor CapitalEventide Asset Managementsanofi-aventisMonograph CapitalVelosity Capital50 South CapitalSeries A
$37,000,000
Series A Investors
Frazier Life SciencesVelosity Capital
Funding info provided by Diffbot.